Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/drawing-shire-parallel-flemming-ornskov-mulls-ipo-for-galderma-reistone-shows-results-from-eczema-study-with-jak1-blocker/
https://endpts.com/fda-offers-support-for-takedas-potential-cytomegalovirus-drug-ahead-of-adcomm/
https://www.fiercebiotech.com/biotech/delix-raises-70m-to-test-psychedelic-analogs-for-treating-brain-disorders-clinical-trials
https://endpts.com/takeda-snaps-up-the-japanese-rights-to-an-old-shire-cast-off-boehringer-ingelheim-acquires-abexxa-biologics/
https://www.fiercepharma.com/pharma/abbvie-dodges-hedge-fund-lawsuit-over-failed-55b-shire-pursuit
https://www.fiercepharma.com/pharma-asia/takeda-offloads-heart-and-metabolism-drugs-to-3-month-old-chinese-firm-for-322m
https://endpts.com/is-takedas-post-shire-sell-off-approaching-its-final-days/
http://www.pharmafile.com/news/554756/takeda-poised-cut-sales-jobs-japan-restructuring-continues
https://endpts.com/takedas-post-merger-deals-continue-as-otc-subsidiary-is-prepared-for-sale/
https://www.fiercepharma.com/marketing/novartis-seeing-no-hope-for-approval-pulls-takeda-bought-dry-eye-med-xiidra-europe